RESUMEN
Since the first report in 1993, an ectopic centromere, i.e. neocentromere formation, has been reported in more than 100 small supernumerary marker chromosomes (sSMC), in 7 instances of centromere repositioning, and in about a dozen cases with more complex chromosomal rearrangements. Here we report 2 new cases with centromere repositioning and 3 neocentric sSMC consisting exclusively of heterochromatic material. Yet, no centromere formation was reported for the regions 18q22.1 and Xq27.1â¼27.2 as it was observed in the 2 cases with centromere repositioning here; in both cases, cytogenetically an inversion was suggested. Two of the 3 neocentric sSMC were derived from a short arm of an acrocentric chromosome. The remainder neocentric sSMC case was previously reported and was stainable only by material derived from itself.
Asunto(s)
Centrómero , Cromosomas Humanos Par 18 , Cromosomas Humanos X , Adulto , Femenino , Humanos , Hibridación Fluorescente in Situ , Lactante , Masculino , EmbarazoRESUMEN
BACKGROUND: Roberts syndrome (RBS) and SC phocomelia are caused by mutations in ESCO2, which codes for an acetyltransferase involved in the regulation of sister chromatid cohesion. Of 26 mutations described to date, only one missense mutation has been reported and all others are predicted to be truncating mutations. Genotype-phenotype analysis has been hampered by limited numbers of patients with clinical information available. OBJECTIVE: To provide unpublished clinical data for 31 patients with proven ESCO2 mutations and combine this series with previously reported clinical and mutation data on 18 cases. Methods Genotype-phenotype correlations and functional effects of two novel ESCO2 mutations were analysed. In situ hybridisation on human embryos at Carnegie stages 14, 17 and 21 was performed to study ESCO2 expression during development. RESULTS AND CONCLUSIONS: Using the cohort of 49 patients, the clinical criteria for RBS were delineated to include: growth retardation; symmetric mesomelic shortening of the limbs in which the upper limbs are more commonly and severely affected than the lower limbs; characteristic facies with microcephaly. The severity of malformations of the facies correlates with the severity of limb reduction. The occurrence of corneal opacities may be associated with specific mutations. Two new mutations, both in the ESCO2 acetyltransferase domain, are described and their acetylation effects in vitro demonstrated. In situ hybridisation on human embryos showed ESCO2 expression in the brain, face, limb, kidney and gonads, which corresponds to the structures affected in RBS.
Asunto(s)
Anomalías Múltiples/genética , Acetiltransferasas/genética , Proteínas Cromosómicas no Histona/genética , Anomalías Craneofaciales/genética , Discapacidades del Desarrollo/genética , Discapacidad Intelectual/genética , Codón/genética , Femenino , Expresión Génica , Variación Genética , Humanos , Lactante , Masculino , Mutación Missense , Fenotipo , Estructura Terciaria de Proteína/genética , Eliminación de Secuencia , SíndromeRESUMEN
Directly transmitted unbalanced chromosomal abnormalities (UBCA) or euchromatic variants (EV) were recently reported for >50 euchromatic regions of almost all human autosomes. UBCA and EV are comprised of a few megabases of DNA, and carriers are in many cases clinically healthy. Here we report on partial trisomies of chromosome 10 within the pericentromeric region which were detected by standard G banding. Those were referred for further delineation of the size of these duplicated regions for molecular cytogenetics and/or array-CGH. Partial trisomies of chromosome 10 in the pericentromeric region were identified prenatally in seven cases. A maximum of three copies of the region from 10p12.1 to 10q11.22 was observed in all cases without apparent clinical abnormalities. The imbalances were either caused by a direct duplication in one familial case or by de novo small supernumerary marker chromosomes (sSMC). Thus, we report a yet unrecognized chromosomal region subject to UBCA detected in seven unrelated cases. To the best of our knowledge, this is the first report of a UBCA in the pericentromeric region of chromosome 10 that is not correlated with any clinical consequences.
Asunto(s)
Aberraciones Cromosómicas , Cromosomas Humanos Par 10 , Amniocentesis , Bandeo Cromosómico , Rotura Cromosómica , Hibridación Genómica Comparativa , Femenino , Dosificación de Gen , Duplicación de Gen , Marcadores Genéticos , Humanos , Hibridación Fluorescente in Situ , Cariotipificación , Masculino , Microdisección , Análisis de Secuencia por Matrices de Oligonucleótidos , Fenotipo , Mapeo Físico de Cromosoma , Diagnóstico PrenatalRESUMEN
Perturbation of the homeostasis between proteases and their inhibitors has been associated with lesion-induced or degenerative neuronal changes. Protease nexin-1 (PN-1), a secreted serine protease inhibitor, is constitutively expressed in distinct neuronal cell populations of the adult CNS. In an earlier study we showed that transgenic mice with ectopic or increased expression of PN-1 in postnatal neurons have altered synaptic transmission. Here these mice are used to examine the impact of an extracellular proteolytic imbalance on long-term neuronal function. These mice develop disturbances in motor behavior from 12 weeks on, with some of the histopathological changes described in early stages of human motor neuron disease, and neurogenic muscle atrophy in old age. In addition, sensorimotor integration, measured by epicranial multichannel recording of sensory evoked potentials, is impaired. Our results suggest that axonal dysfunction rather than cell death underlies these phenotypes. In particular, long projecting neurons, namely cortical layer V pyramidal and spinal motor neurons, show an age-dependent vulnerability to PN-1 overexpression. These mice can serve to study early stages of in vivo neuronal dysfunction not yet associated with cell loss.
Asunto(s)
Proteínas Portadoras/biosíntesis , Enfermedad de la Neurona Motora/enzimología , Enfermedad de la Neurona Motora/genética , Neuronas Motoras/metabolismo , Células Piramidales/metabolismo , Precursor de Proteína beta-Amiloide , Animales , Axones/patología , Conducta Animal , Encéfalo/metabolismo , Encéfalo/patología , Proteínas Portadoras/genética , Progresión de la Enfermedad , Electroencefalografía , Potenciales Evocados/genética , Femenino , Gliosis/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes Neurológicos , Ratones Transgénicos , Actividad Motora/genética , Enfermedad de la Neurona Motora/diagnóstico , Enfermedad de la Neurona Motora/patología , Neuronas Motoras/patología , Atrofia Muscular/genética , Atrofia Muscular/patología , Nexinas de Proteasas , Células Piramidales/patología , Receptor de Factor de Crecimiento Nervioso , Receptores de Superficie Celular , Receptores de Factor de Crecimiento Nervioso/metabolismo , Inhibidores de Serina Proteinasa/biosíntesis , Inhibidores de Serina Proteinasa/genética , Serpina E2 , Médula Espinal/metabolismo , Médula Espinal/patología , Tasa de Supervivencia , Pérdida de Peso/genéticaRESUMEN
Mutations in the MECP2 (Methyl-CpG-binding protein) gene recently have been reported to cause Rett syndrome (RTT), an X-linked dominant neurodevelopmental disease. We investigated 125 sporadic cases of Rett syndrome by direct sequencing. Thirty different mutations were found in 97 patients with Rett syndrome. Seventeen mutations have not been described previously. We provide evidence for the existence of several hot spot regions and of a deletion-prone region located at the 3' most region of the gene. This latter region most probably forms secondary structures in vitro. Similar structures in vivo could explain the high frequency of deletions in this region. Nine of 10 recurrent mutations were located in either the methyl CpG binding domain (MBD) or in the transcriptional repression domain (TRD), and all missense mutations were located in one of these functionally important domains. There was a high frequency of more than 60% of truncating mutations (nonsense mutations along with frameshift mutations). One patient with a mild form of the disease and a normal head growth carries a novel c.27-6C>A mutation that causes a cryptic splice site in intron I resulting in a frameshift transcript. The detection rate in our collective was 77.6%. Our findings show that the majority of German Rett patients carry mutations in the MECP2 gene confirming the suggested locus homogeneity for the disease.
Asunto(s)
Proteínas Cromosómicas no Histona , Proteínas de Unión al ADN/genética , Proteínas Represoras , Síndrome de Rett/genética , Secuencia de Bases , Sitios de Unión/genética , ADN/química , ADN/genética , Análisis Mutacional de ADN , Femenino , Alemania , Humanos , Proteína 2 de Unión a Metil-CpG , MutaciónRESUMEN
Usher syndrome (USH) is a clinically and genetically heterogeneous autosomal recessive disorder in which sensorineural hearing loss is associated with retinitis pigmentosa. Usher syndrome type 1, the most severe form, is characterized by profound congenital deafness, vestibular dysfunction, and prepubertal onset of retinitis pigmentosa. Six different USH1 genes have so far been mapped, of which two have already been identified. MYO7A, encoding the unconventional myosin VIIA, underlies USH1B. Recently, the USH1C gene was shown to encode harmonin, a PDZ domain-containing protein. A previous screening of 18 unrelated USH1 patients, without a detected MYO7A mutation, for the three USH1C mutations described to date had demonstrated the presence of the 238-239insC mutation in the heterozygous state in four of them. A complete USH1C mutation screening in these four carriers of the 238-239insC mutation resulted in the detection of the second mutation in all the individuals, and the identification of three novel mutations, namely two splice site mutations (IVS1+1G>T and IVS5+1G>A) and a nonsense mutation (R31X). Thirty-one polymorphisms were detected in the USH1C gene. We observed that the E519D substitution is non-pathogenic, which is of particular interest for molecular diagnosis. Our analysis indicated that all the carriers of the 238-239insC mutation share a common haplotype. A different common haplotype was found in the two IVS1+1G>T carriers. Future studies of additional carriers and non-carriers should document the here proposed founder effect of these two mutations.
Asunto(s)
Anomalías Múltiples/genética , Sordera/genética , Haplotipos/genética , Mutación , Polimorfismo Genético/genética , Retinitis Pigmentosa/genética , Proteínas Adaptadoras Transductoras de Señales , Empalme Alternativo/genética , Sustitución de Aminoácidos/genética , Proteínas Portadoras/genética , Proteínas de Ciclo Celular , Niño , Codón sin Sentido/genética , Proteínas del Citoesqueleto , Análisis Mutacional de ADN , Sordera/congénito , Femenino , Tamización de Portadores Genéticos , Humanos , Masculino , Mutación Missense/genética , Retinitis Pigmentosa/congénito , SíndromeRESUMEN
PURPOSE: To examine the role of Drosophila optomotor blind (omb)-related T-box genes in development of human and mouse retina. METHODS: Mouse Tbx2, Tbx3, and Tbx5 and human TBX2 cDNAs were isolated from retinal cDNA libraries by hybridization to the Drosophila omb gene. Gene expression patterns in developing retina were analyzed by in situ hybridization. RESULTS: TBX2/Tbx2, TBX3/Tbx3, and TBX5/Tbx5 were expressed asymmetrically across the embryonic neural retina with highest levels of mRNA within dorsal and peripheral retina. The dorsoventral gradient of TBX2 expression disappeared before the ganglion cell layer (GCL) formed. Its expression then became restricted to the inner neuroblastic retina and later to the GCL and inner nuclear layer (INL). The dorsal expression domains of TBX5/Tbx5 and TBX3/Tbx3 were maintained during formation of the GCL. As the retina matured, TBX3/Tbx3 expression was restricted to the INL, and TBX5/Tbx5 was expressed within the GCL. CONCLUSIONS: The expression pattern of TBX2, TBX3, and TBX5 within the developing retina supports the idea that the encoded transcription factors play a role in providing positional information important for topographic mapping and in differentiation of distinct cell types across the laminar axis of the retina.
Asunto(s)
Proteínas de Drosophila , Expresión Génica , Ratones/genética , Retina/embriología , Proteínas de Dominio T Box/genética , Animales , Desarrollo Embrionario y Fetal , Ojo/embriología , Feto/fisiología , Edad Gestacional , Humanos , Masculino , Ratones Endogámicos C57BL , Persona de Mediana Edad , Proteínas del Tejido Nervioso/genética , Retina/fisiologíaAsunto(s)
Cromosomas Humanos X , Duplicación de Gen , Proteína 2 de Unión a Metil-CpG/genética , Síndrome de Rett/diagnóstico , Síndrome de Rett/genética , Niño , Femenino , Dosificación de Gen , Expresión Génica , Humanos , Hibridación Fluorescente in Situ , Masculino , Proteína 2 de Unión a Metil-CpG/metabolismo , LinajeAsunto(s)
Infarto Cerebral/diagnóstico , Neuropatía Óptica Isquémica/diagnóstico , Baja Visión/etiología , Anciano , Anciano de 80 o más Años , Infarto Cerebral/etiología , Diagnóstico Diferencial , Dominancia Cerebral/fisiología , Femenino , Angiografía con Fluoresceína , Humanos , Neuropatía Óptica Isquémica/etiología , Tomografía Computarizada por Rayos X , Campos Visuales/fisiologíaRESUMEN
Alexander disease is a rare disorder of cerebral white matter due to a dysfunction of astrocytes. The most common infantile form presents as a megalencephalic leukodystrophy. Mutations of the GFAP gene, encoding Glial Fibrillary Acidic Protein, have been recognized as the cause of Alexander disease. Glial Fibrillary Acidic Protein is the major intermediate filament protein in astrocytes, its functional rod domain is conserved in sequence and structure among other intermediate filament proteins. We report here two cases of infantile Alexander disease with early onset and severe course, caused by DE NOVO mutations A364 V and Y366C. Both affected GFAP residues are part of a highly conserved coiled-coil trigger motif in the C-terminal end of segment 2B, probably required for the stability of intermediate filament molecules. Comparable effects are seen with mutations of the corresponding residues of the gene coding for keratin 14, another intermediate filament, this further supports the hypothesis that these positions of the trigger motif are generally critical for a normal function of intermediate filaments.
Asunto(s)
Enfermedad de Alexander/genética , Exones/genética , Proteína Ácida Fibrilar de la Glía/genética , Mutación/genética , Edad de Inicio , Alanina/genética , Enfermedad de Alexander/patología , Cisteína/genética , Análisis Mutacional de ADN/métodos , Femenino , Lóbulo Frontal/patología , Humanos , Lactante , Imagen por Resonancia Magnética/métodos , Masculino , Estructura Terciaria de Proteína/genética , Tirosina/genética , Valina/genéticaRESUMEN
The membrane subunit (IIGlc) of the glucose permease has been purified from overproducing Escherichia coli. About 2 mg of pure protein was obtained from 10 g (wet weight) of cells. IIGlc of E. coli and Salmonella typhimurium are functionally indistinguishable. A small difference was revealed, however, by a monoclonal antibody which neutralizes glucose phosphorylation activity of IIGlc from S. typhimurium, but does not cross-react with IIGlc of E. coli. A dimeric form of purified IIGlc can be detected by chemical cross-linking and by zonal sedimentation at 4 degrees C. Upon mild oxidation a disulfide bond is formed between the subunits of the dimer. Oxidized IIGlc is more stable than the reduced form but is inactive because it cannot be phosphorylated by the cytoplasmic subunit (IIIGlc) of the glucose permease. Cys-421 could be identified as the oxidation-sensitive residue, using a novel assay to detect IIIGlc-dependent phosphorylation of nitrocellulose-bound IIGlc that has been purified by gel electrophoresis. No dimeric form of phosphorylated IIGlc could be detected. Because phosphorylated IIGlc is a catalytic intermediate it is concluded that catalytically active IIGlc is a monomer and that the dimeric form is an artefact observed only with purified resting IIGlc. That IIGlc is active as a monomer is further supported by the observation that monomeric IIGlc catalyzes phosphoryl exchange between glucose and glucose 6-phosphate at equilibrium and that an excess of inactive IIGlc with a serine replacing Cys-421 does not interfere with the activity of wild-type IIGlc as would be expected if interaction between the subunits in a dimer were essential for activity.
Asunto(s)
Escherichia coli/enzimología , Sistema de Fosfotransferasa de Azúcar del Fosfoenolpiruvato/aislamiento & purificación , Sustancias Macromoleculares , Oxidación-Reducción , Fosforilación , Salmonella typhimurium/enzimologíaRESUMEN
BACKGROUND: Lattice corneal dystrophy type I is one of the frequent forms of stromal dystrophies following autosomal dominant inheritance. The beta-IG-h3 gene encoding keratoepithelin on the long arm of chromosome 5 has recently been described as disease gene for lattice corneal dystrophy type I as well as for three other corneal dystrophies with autosomal dominant pattern of inheritance. PATIENTS AND METHODS: Ten family members in three generations of a large family with autosomal dominant lattice corneal dystrophy were analyzed clinically by slit-lamp biomicroscopy. Mutation analysis in the beta-IG-h3 gene was carried out at the mRNA level by RT-PCR and cDNA sequencing. RESULTS: A heterozygous single-base substitution (417C-->T) in exon 4 of the beta-IG-h3 gene was detected predicting the replacement of arginine-124 by cysteine. Analysis of 10 family members showed perfect cosegregation of the mutation and lattice corneal dystrophy type I. The investigation excluded this mutation in one family member previously classified as potentially affected. CONCLUSIONS: The investigation confirmed autosomal dominant inheritance with complete penetrance in the family described. The mutation 417C-->T has already been found earlier in another family of different geographic origin. These results suggest a mutation hot spot at position 417. In addition, no evidence of genetic heterogeneity of lattice corneal dystrophy type I was detected. Molecular genetic analysis (in conjunction with genetic counselling) therefore may be useful in routine diagnostics as the confirmation of the diagnosis by histological examination is possible only after keratoplasty. The common pathomechanism in lattice corneal dystrophy type I may facilitate development of new therapeutic concepts; the easy accessibility of the target organ may provide new possibilities e.g. for gene therapy.
Asunto(s)
Aberraciones Cromosómicas/genética , Cromosomas Humanos Par 5 , Distrofias Hereditarias de la Córnea/genética , Proteínas de la Matriz Extracelular/genética , Proteínas del Ojo/genética , Genes Dominantes/genética , Adulto , Anciano , Trastornos de los Cromosomas , Distrofias Hereditarias de la Córnea/clasificación , Distrofias Hereditarias de la Córnea/diagnóstico , Análisis Mutacional de ADN , ADN Complementario/genética , Femenino , Tamización de Portadores Genéticos , Humanos , Masculino , Persona de Mediana Edad , Linaje , Reacción en Cadena de la Polimerasa , ARN Mensajero/genéticaRESUMEN
Rett syndrome (RTT) is an X-linked neurodevelopmental disorder that apparently is lethal in male embryos. RTT almost exclusively affects female offspring and, in 99.5% of all cases, is sporadic and due to de novo mutations in the MECP2 gene. Familial cases of RTT are rare and are due to X-chromosomal inheritance from a carrier mother. We analyzed the parental origin of MECP2 mutations in sporadic cases of RTT, by analysis of linkage between the mutation in the MECP2 gene and intronic polymorphisms in 27 families with 15 different mutations, and we found a high predominance of mutations of paternal origin in 26 of 27 cases (P<.001). The paternal origin was independent of type of mutation and was found for single-base exchanges as well as for deletions. Parents were not of especially advanced age. We conclude that de novo mutations in RTT occur almost exclusively on the paternally derived X chromosome and that this is most probably the cause for the high female:male ratio observed in patients with RTT. Affected males recently have been described in a few cases of familial inheritance. Identification of the parental origin may be useful to distinguish between the sporadic form of RTT and a potentially familial form. This distinction will allow geneticists to offer more-specific counseling and discriminate between higher (maternal origin) and lower (paternal origin) recurrence risk.
Asunto(s)
Proteínas Cromosómicas no Histona , Proteínas de Unión al ADN/genética , Mutación/genética , Proteínas Represoras , Síndrome de Rett/genética , Cromosoma X/genética , Adulto , Alelos , Secuencia de Bases , Análisis Mutacional de ADN , Femenino , Frecuencia de los Genes/genética , Asesoramiento Genético , Ligamiento Genético/genética , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Intrones/genética , Masculino , Edad Materna , Proteína 2 de Unión a Metil-CpG , Datos de Secuencia Molecular , Edad Paterna , Mutación Puntual/genética , Polimorfismo de Nucleótido Simple/genética , Eliminación de Secuencia/genética , Distribución por SexoRESUMEN
Alexander disease (AD) is a rare disorder of cerebral white matter due to a dysfunction of astrocytes. The most common infantile form presents as a megalencephalic leukodystrophy. Recently, heterozygous de novo mutations in the glial fibrillary acidic protein gene (GFAP) have been demonstrated to be associated with AD. We report heterozygous mutations in GFAP in 5 patients, including a pair of monozygotic twins, with clinical and neuroradiological features of infantile AD. Novel mutations were detected affecting nucleotides 304 T --> C (L97 P) and 730 G --> C (R239 P) in two other patients. None of the parents of our patients carried the mutations stressing dominant de novo mutations as the cause of AD. The presence of an identical mutation 250 G --> A (R79 H) in both monozygotic twins with infantile AD points to the origin of these GFAP mutations in germ cells or very early postzygotic stages.
Asunto(s)
Enfermedad de Alexander/genética , Proteína Ácida Fibrilar de la Glía/genética , Mutación/genética , Gemelos Monocigóticos/genética , Niño , Preescolar , Análisis Mutacional de ADN , Humanos , Lactante , Recién Nacido , Masculino , PronósticoRESUMEN
T-box transcription factors contain a novel type of DNA-binding domain, the T-box domain, and are encoded by an ancient gene family. Four T-box genes, omb, Trg, org-1, and H15, have been identified in Drosophila, whereas in mammals the T-box gene family has expanded, and 12 human T-box genes have been isolated. We have identified a new human T-box gene, TBX20, and its mouse homologue Tbx20, which are more closely related to the Drosophila H15 gene than to any known vertebrate gene. H15 expression in leg imaginal discs correlates with commitment to a ventral fate, implicating this gene in early patterning events. We find that TBX20 is expressed in the fetal heart, eye, and limb, and during embryogenesis in the mouse, Tbx20 is expressed in the developing heart, eye, ventral neural tube, and limbs, indicating a possible role in regulating development of these tissues. The TBX20 gene maps to chromosome 7p14-p15. An association between TBX20 and loci for retinitis pigmentosa, RP9, and blepharophimosis syndrome, BPES, have been excluded.
Asunto(s)
Drosophila/genética , Proteínas de Dominio T Box/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Tipificación del Cuerpo , Cromosomas Humanos Par 7 , Cartilla de ADN/química , Embrión de Mamíferos/metabolismo , Embrión no Mamífero , Extremidades/embriología , Extremidades/fisiología , Ojo/embriología , Ojo/metabolismo , Femenino , Expresión Génica , Corazón/embriología , Humanos , Hibridación in Situ/métodos , Ratones , Datos de Secuencia Molecular , Miocardio/metabolismo , Embarazo , Retinitis Pigmentosa/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de Aminoácido , Proteínas de Dominio T Box/biosíntesisRESUMEN
The glucose transporter (IIBCGlc/IIAGlc complex) of the bacterial phosphotransferase system couples vectorial translocation to phosphorylation of the transported sugar. The IIAGlc subunit transfers the phosphoryl group from the phosphoryl carrier protein P-HPr to the IIBCGlc subunit. IIBCGlc translocates and phosphorylates glucose. The site of IIBCGlc phosphorylation is cysteine 421 as shown by mass spectrometric and biochemical analyses of phosphorylated peptides. Site-directed mutagenesis of Cys421 (C421S) afforded a stable but completely inactive protein (Nuoffer, C., Zanolari, B., and Erni, B. (1988) J. Biol. Chem. 263, 6647-6655). Cys421 is located in the C-terminal cytoplasmic domain of the IIBCGlc subunit in a sequence context (LDACITRL) which is well conserved in other transporters of the bacterial phosphotransferase system. Phosphocysteine has been shown previously to be the catalytic intermediate of the mannitol transporter (Pas, H. H., Meyer, G. H., Kruizinga, W. H., Tamminga, K. S., van Weeghel, R. P., and Robillard, G. T.
Asunto(s)
Cisteína/metabolismo , Escherichia coli/metabolismo , Proteínas de Transporte de Monosacáridos/metabolismo , Sistema de Fosfotransferasa de Azúcar del Fosfoenolpiruvato/metabolismo , Secuencia de Aminoácidos , Cromatografía Líquida de Alta Presión , Concentración de Iones de Hidrógeno , Cinética , Espectrometría de Masas , Datos de Secuencia Molecular , Proteínas de Transporte de Monosacáridos/química , Fragmentos de Péptidos/química , Fragmentos de Péptidos/aislamiento & purificación , Fosfoenolpiruvato/metabolismo , Sistema de Fosfotransferasa de Azúcar del Fosfoenolpiruvato/química , Fosfopéptidos/química , Fosfopéptidos/aislamiento & purificación , Radioisótopos de Fósforo , FosforilaciónRESUMEN
Protease Nexin-1 (PN-1) also known as Glia-Derived Nexin (GDN) inhibits the activity of several serine proteases including thrombin, tissue (tPA)- and urokinase (uPA)-type plasminogen activators. These and other serine proteases seem to play roles in development and tissue homeostasis. To gain insight into where and when PN-1 might counteract serine protease activities in vivo, we examined its mRNA and protein expression in the mouse embryo, postnatal developing nervous system and adult tissues. These analyses revealed distinct temporal and spatial PN-1 expression patterns in developing cartilage, lung, skin, urogenital tract, and central and peripheral nervous system. In the embryonic spinal cord, PN-1 expression occurs in cells lining the neural canal that are different from the cells previously shown to express tPA. In the developing postnatal brain, PN-1 expression appears transiently in many neuronal cell populations. These findings suggest a role for PN-1 in the maturation of the central nervous system, a phase that is accompanied by the appearance of different forms of PN-1. In adults, few distinct neuronal cell populations like pyramidal cells of the layer V in the neocortex retained detectable levels of PN-1 expression. Also, mRNA and protein levels did not correspond in adult spleen and muscle tissues. The widespread and complex regulation of PN-1 expression during embryonic development and, in particular, in the early postnatal nervous system as well as in adult tissues suggests multiple roles for this serine protease inhibitor in organogenesis and tissue homeostasis.
Asunto(s)
Proteínas Portadoras/genética , Desarrollo Embrionario y Fetal/genética , Sistema Nervioso/embriología , Inactivadores Plasminogénicos/genética , Precursor de Proteína beta-Amiloide , Animales , Northern Blotting , Expresión Génica/fisiología , Inmunohistoquímica , Hibridación in Situ , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Nexinas de Proteasas , Receptores de Superficie CelularRESUMEN
RNA-binding proteins are involved in post-transcriptional processes like mRNA stabilization, post-transcriptional modification, and transport and have been suggested to play an important role in developmental gene regulation. We report here the cloning and characterization of Brunol4, a novel mouse cDNA closely related to the elav-type family of genes encoding for RNA-binding proteins and a subfamily recently named after the bruno gene of Drosophila. Murine Brunol4 is localized near the centromere of chromosome 18. The cDNA sequence of Brunol4 is separated by 12 introns and the size of Brunol4 may be around 250 kb due to the large size of several introns. Brunol4 expression is detectable in the developing embryo and, later on becomes mainly restricted to cerebral structures, in particular the cerebellum where it persists in the adult organism. We predict a role of Brunol4 and the respective human homologue in differentiation and maintenance of neuronal structures.
Asunto(s)
Proteínas de Drosophila/genética , Proteínas de Unión al ARN/genética , Ribonucleoproteínas/genética , Animales , Secuencia de Bases , Proteínas CELF , Mapeo Cromosómico , ADN Complementario , Proteínas ELAV , Ratones , Datos de Secuencia Molecular , Proteínas de Unión al ARN/química , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
Usher syndrome is a heterogeneous autosomal recessive trait and the most common cause of hereditary deaf-blindness. Usher syndrome type I (USH1) is characterised by profound congenital sensorineural hearing loss, vestibular dysfunction, and prepubertal onset of retinitis pigmentosa. Of the at least six different loci for USH1, USH1B maps on chromosome 11q13, and the MYO7A gene has been shown to be defective in USH1B. MYO7A encodes myosin VIIA, an unconventional myosin, and it consists of 48 coding exons. In this study, MYO7A was analysed in 34 unrelated Usher type I patients by single-strand conformation polymorphism analysis and direct sequencing. We identified a total of 12 novel and unique mutations, all single base changes. In addition, we found a previously reported nonsense mutation (C31X) on nine alleles of a total of six patients from Denmark.